AT
LLY icon

Arlington Trust’s Eli Lilly LLY Stock Holding History

Arlington Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
278
+1
+0.4% +$1.02K 0.03% 80
2026
Q1 		$255K Buy
277
+113
+69% +$115K 0.02% 78
2025
Q4 		$176K Sell
164
-2,113
-93% -$2.02M 0.02% 97
2025
Q3 		$1.74M Buy
2,277
+21
+0.9% +$15.6K 0.31% 40
2025
Q2 		$1.76M Sell
2,256
-128
-5% -$99.5K 0.34% 36
2025
Q1 		$1.97M Sell
2,384
-83
-3% -$69.1K 0.42% 33
2024
Q4 		$1.9M Sell
2,467
-122
-5% -$101K 0.4% 30
2024
Q3 		$2.29M Sell
2,589
-39
-1% -$35.1K 0.5% 26
2024
Q2 		$2.38M Sell
2,628
-73
-3% -$58.4K 0.56% 27
2024
Q1 		$2.1M Sell
2,701
-84
-3% -$59.8K 0.54% 26
2023
Q4 		$1.62M Buy
2,785
+2,328
+509% +$1.36M 0.46% 32
2023
Q3 		$245K Buy
+457
New +$235K 0.1% 77

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arlington Trust's LLY Position: Q2 2026 in Review

Arlington Trust increased its Eli Lilly (LLY) stake by 0.36% in Q2 2026, buying an estimated $1.02K and bringing the position to 278 shares worth $333K. The position accounts for 0.03% of the portfolio, ranked #80.

Arlington Trust first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.38M in Q2 2024. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arlington Trust held 278 shares of Eli Lilly worth $333K as of Q2 2026.
  • Arlington Trust bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.03% of Arlington Trust's portfolio in Q2 2026, its #80 holding.
  • Arlington Trust first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Eli Lilly position peaked at $2.38M in Q2 2024.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.